SenesTech and Distribution Partner to Bring
Evolve™ to New Zealand's Predator
Free 2050 Initiative
PHOENIX, Feb. 25,
2025 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES),
a pioneer in fertility control solutions for managing rodent
populations, is pleased to announce a significant milestone in its
expansion into vast and largely untapped markets for rodent
fertility control across New
Zealand and Australia. In
partnership with Evicom, a provider of environmental consulting,
on-ground environmental management and wildlife control and
management services across Australia and New
Zealand, SenesTech is bringing Evolve™ Rat and Evolve™ Mouse
to the forefront of integrated pest management (IPM) solutions in
the region.
Following the submission of Evolve for regulatory approval in
New Zealand, the company
anticipates final approval in the third quarter of 2025, with
stocking shipments beginning as early as late second quarter or
early third quarter. This approval marks a transformational step in
the way rodent populations are managed, offering a solution that is
not only highly effective but also aligns with the strong
environmental and ecological priorities of New Zealand and Australia.
Unlocking a Sustainable and Humane Alternative for Rodent
Control
Rodent overpopulation remains a major ecological and
economic challenge in both countries, threatening native
wildlife, agriculture, and urban environments. Traditional
rodenticides, while effective in the short term, pose significant
risks to non-target species, the food chain, and the broader
ecosystem. By contrast, Evolve is a revolutionary birth
control solution that restricts rodent reproduction at
its source, offering a non-lethal, environmentally responsible
alternative that seamlessly integrates into existing IPM
strategies.
A Perfect Fit for New Zealand's
Predator Free 2050 Vision
New Zealand's Predator
Free 2050 initiative is one of the most ambitious conservation
programs in the world, aiming to eradicate invasive predators such
as rats, stoats, and possums to safeguard native
species. New Zealand expects to spend over $4.5 billion on this program, explicitly counting
on advancements in technology and the development of more efficient
and effective eradication methods to accomplish their goals. Evolve
represents an ideal partner for this effort, as it reduces rat
populations without the collateral damage of poisons,
preserving biodiversity and delicate ecosystems in line
with New Zealand's conservation
goals.
Expansion Opportunities in Australia's Growing Market
Beyond New Zealand, Australia presents another major growth
opportunity. It is estimated that Australia currently spends $100 million on rodent pest control annually,
with the spend growing at over 5% per year. With escalating
concerns over rodent infestations in ecologically sensitive
habitat, agricultural, commercial, and urban settings, the adoption
of sustainable pest management solutions is a rising
priority. Evolve's environmental safety, ease of integration,
and long-term efficacy position it as a game-changing
solution for both government-backed conservation programs and
private sector pest control initiatives.
A Market Poised for Rapid Growth
"By expanding into New Zealand and Australia we are delivering on our strategy to
become the global leader in humane and sustainable fertility
control solutions for managing rat populations, while tapping
into significant, high-growth markets that are actively
seeking sustainable, humane, and effective
alternatives to traditional rodenticides," said Joel
Fruendt, President and CEO of SenesTech. "Evolve reduces
reliance on poisons, aligning with changing regulatory
standards and environmental policies. This is especially
crucial for New Zealand,
where protecting native wildlife is a national priority, and for
Australia, where large-scale
agricultural and urban pest control efforts demand more
responsible solutions."
With Evicom's broad network and strong government and
private sector partnerships, SenesTech expects the regional
annual demand for Evolve Rodent Birth Control to rapidly reach or
exceed $500,000, further solidifying
its position as a leader in innovative pest control
solutions.
About SenesTech, Inc.
SenesTech is committed to creating healthier environments by
humanely managing animal pest populations through fertility
control. The company's groundbreaking products, including Evolve
rodent birth control, integrate seamlessly into pest management
programs, significantly enhancing their effectiveness while
reducing reliance on traditional poisons. SenesTech's mission is to
create cleaner cities, more efficient businesses, and healthier
communities with products that are humane, effective, and
sustainable.
For more information, visit https://senestech.com.
Safe Harbor Statement
This press release contains forward-looking statements within
the meaning of federal securities laws, and we intend that such
forward-looking statements be subject to the safe harbor created
thereby. Such forward-looking statements include, among others, our
anticipation of final regulatory approval in New Zealand for Evolve in the third quarter of
2025; our anticipation of stocking shipments to begin in
New Zealand as early as late
second quarter or early third quarter of 2025; our belief that the
regulatory approval in New Zealand
is a transformational step in the way rodent populations are
managed; our belief that Evolve is a solution that is highly
effective and aligns with the strong environmental and ecological
priorities of New Zealand and
Australia; our belief that Evolve
is a non-lethal, environmentally responsible alternative that
seamlessly integrates into IPM strategies; our belief that Evolve
is a perfect fit for New Zealand's
Predator Free 2050 vision; our belief that New Zealand's Predator Free 2050 initiative is
one of the most ambitious conservation programs in the world; our
believe that Evolve represents an ideal partner for New Zealand's Predator Free 2050 initiative;
our belief that Australia presents
a major growth opportunity; our belief that Evolve's environmental
safety, ease of integration, and long-term efficacy position is a
game-changing solution for both New
Zealand and Australia's
government-backed conservation programs and private sector pest
control initiatives; our belief that by expanding into New Zealand and Australia, we are delivering on our strategy
to become the global leader in humane and sustainable fertility
control solutions for managing rat populations, while tapping into
significant, high-growth markets that are actively seeking
sustainable, humane, and effective alternatives to traditional
rodenticides; our belief that because Evolve reduces the reliance
on poisons, which aligns with changing regulatory standards and
environmental policies, it is especially crucial for New Zealand and Australia; our expectation that the regional
annual demand for Evolve to rapidly reach or exceed $500,000; and our belief that Evicom will further
solidify our position as a leader in innovative pest control
solutions. Forward-looking statements may describe future
expectations, plans, results, or strategies and are often,
but not always, made through the use of words such as "believe,"
"may," "future," "plan," "will," "should," "expect," "anticipate,"
"eventually," "project," "estimate," "continuing," "intend" and
similar words or phrases. You are cautioned that such statements
are subject to risks, uncertainties and other factors that could
cause actual results to differ materially from those reflected by
such forward-looking statements. Such factors include, among
others, the successful commercialization of our products; market
acceptance of our products; our financial performance, including
our ability to fund operations; our ability to regain and maintain
compliance with Nasdaq's continued listing requirements; regulatory
approval and regulation of our products; and other factors and
risks identified from time to time in our filings with the
Securities and Exchange Commission, including our Annual Report on
Form 10-K for the fiscal year ended December
31, 2023. All forward-looking statements contained in this
press release speak only as of the date on which they were made and
are based on management's assumptions and estimates as of such
date. Except as required by law, we do not undertake any obligation
to publicly update any forward-looking statements, whether as a
result of the receipt of new information, the occurrence of future
events or otherwise.
Investor Contact:
Robert Blum, Lytham Partners,
LLC
(602) 889-9700, senestech@lythampartners.com
Marketing Contact:
Rochelle Paulet, SenesTech, Inc.
(928) 779-4143, marketing@senestech.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-expands-its-rapidly-growing-global-footprint-and-clears-major-regulatory-hurdle-paving-the-way-for-use-in-australia-and-new-zealand-302384771.html
SOURCE SenesTech, Inc.
